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Abstract: Dyes are known to be a causative agent of occupational asthma in workers 
exposed to them. We have evaluated respiratory symptoms among textile workers. The 
study population comprised 106 exposed workers and a control (unexposed) group. Data 
were collected by a questionnaire. PFTs (Pulmonary Function Test) were performed. 
Among the exposed workers 36.8% defined phlegm. Respiratory symptoms were not 
significantly different between two groups. The employment duration of the exposed 
workers with phlegm was longer than those without phlegm (p = 0.027). The mean % 
predicted of FEF25–75 of the exposed workers was found to be significantly lower than the 
control (unexposed) group (p = 0.01). Our study suggests that textile dyeing might cause 
respiratory symptoms in workers.  
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1. Introduction 
Dyes, especially reactive ones, are known to be a causative agent of occupational asthma, rhinitis 
and dermatitis in workers exposed to them [1–4]. Docker et al. showed that more than 15% of workers 
handling reactive dyes had work-related respiratory or nasal symptoms and considered that the 
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symptoms could be attributed to an irritant response to chemicals used in this industry, including 
hydrochloric acid vapor, sulfur dioxide, as well as the reactive dyes themselves [5]. 
There are numerous publications on the effect of dust on the respiratory system of textile workers 
employed in processing textile materials such as cotton, hemp, flax and wool [6–14]. However, there 
are few available studies on respiratory function in the workers employed in the textile dyeing  
industry [15]. Viegi et al. evaluated respiratory functions in workers of a dyeing factory and found the 
prevalence of chronic bronchitis and dyspnea to be 32%, flow rates were significantly lower than 
reference values [16]. 
We planned this study to evaluate chronic respiratory symptoms among textile workers exposed to 
textile dyes and compare the respiratory symptoms and Pulmonary Function Test (PFT) results of 
exposed workers with a control group who were not exposed to textile dyes at work. To the best of our 
knowledge, this is the first study in our country (Turkey) which evaluates respiratory symptoms and 
PFTs of textile workers exposed to textile dyes. 
2. Material and Methods 
2.1. Background 
This study was conducted at textile dyeing factories. Among the textile dyeing factories located in 
the Denizli Industrial Zone, which has over a hundred textile factories, three of them which have given 
permission for the study were included in the research. These factories were experts in textile dyeing, 
and had over two hundred workers at each.  
2.2. Patients and Study Design 
Data were collected from 106 exposed workers and 106 in the control (unexposed) group (only 
working in the managerial departments of the textile dyeing factories). To avoid collection bias, all 
data for the exposed workers, including questionnaires, were collected by two experienced 
pulmonologists. Data on demographics, episodes of wheezing or chest tightness, symptoms of 
dyspnea, cough, phlegm, any other allergic and/or respiratory symptoms, duration of symptoms, past 
medical history (Are there any pulmonary diseases which were diagnosed by a doctor in the past? and 
pulmonary diseases that were not particularly investigated but might be were related to their 
occupational history, were identified by a questionnaire), smoking habits were determined by a 
questionnaire modified from the American Thoracic Society Questionnaire [17]. The questionnaire was 
administered in a person to person interview. 
Pulmonary function tests were performed with a portable spirometer (MIR Spirobank) according to 
American Thoracic Society criteria while the patients were at rest and seated in the upright position.  
A minimum of three satisfactory forced expiratory manoeuvers was required of each subject.  
A satisfactory test required that the forced vital capacity (FVC) and forced expiratory volume in 1 second 
(FEV1) of two manoeuvers was reproducible within 5% [18]. Analyses were performed on the largest 
FVC and FEV1 expressed as percentage of the predicted value. The FVC, FEV1 and forced expiratory 
flow at 25% to 75% of the FVC (FEF25–75) and peak expiratory flow (PEF) were determined. 
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Non-smokers were defined as those who had never smoked regularly, smokers were currently 
smoking at least one cigarette daily, ex-smokers were those who had formerly smoked regularly but 
gave it up at least 6 months before the study. Control (unexposed) subjects (n = 106) were employees 
in the managerial departments of the textile dyeing factories and had similar age, sex, smoking habits, 
social and economic status. The same questionnaire and PFTs were administered to the control group. 
2.3. Textile Dyeing Procedure 
The dyeing was performed in several large open vats located in a large area with a temperature of  
60 °C to 80 °C. The cotton materials were first sorted by type and then manually placed into vats and 
boiled for one hour. 
The dyeing process used different types of commercially available azo and reactive dyes in addition 
to many other chemical agents. The dyes included: reactive dyes; azo and anthraquinone derivatives. 
The dyes were purchased from Germany. 
Before dyeing, the materials are treated with acetic acid (CH3COOH), formic acid (HCOOH), 
sodium hydroxide (NaOH), sodium hydrosulphide (NaHS). At high temperatures vapors of different 
agents are released, including hydrogen (H2S) and nitrogen oxides (when azo dyes are used), as well as 
other vapors released from dyes, which may be found in the workplace atmosphere and inhaled by 
exposed workers. These workers were also exposed to high temperatures and to a high relative humidity 
in the workplace. Measurements of dusts, fumes and gases [acetic acid (CH3COOH), formic acid 
(HCOOH), sodium hydroxide (NaOH), sodium hydrosulphide (NaHS)] were not performed in the 
workplaces. 
2.4. Statistical Analysis 
Descriptive statistics (including Mean ± SD, frequency and percentage) were calculated for two 
groups separately. The difference between the means of variables in two groups was compared using 
Independent Samples t test and the difference between the medians of variables in two groups was 
compared using Mann Whitney U test. The Chi-Square test was used to compare categorical variables. 
The statistical significance was set at p < 0.05. The statistical analyses were performed with the 
statistical package program SPSS version 11.5. 
3. Results 
3.1. Characteristics of Patients 
Our study population comprised 106 exposed workers (23.6% female and 76.4% male) with a mean 
age of 29.51 ± 0.56 years. Employment duration of the exposed workers was 65.39 ± 55.69 months. 
Control group (unexposed) comprised 106 workers (16% female, 84% male) with a mean age of  
30.91 ± 0.78 years. The demographics and smoking data of the two groups are presented in Table 1. A 
significant correlation was detected between cigarette smoking and phlegm, wheezing and dyspnea  
(p = 0.005, p = 0.02, p = 0.033 respectively). 
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Table 1. The descriptive statistics (Mean ± SD, frequency and percentage) of the exposed 
workers and control (unexposed) group. 
 
Exposed workers 
(n = 106) 
Control (unexposed) 
group(n = 106) 
p 
Mean age (±SD) 29.51 ± 0.56 30.91 ± 0.78 NS 
Number of females 25 (23.6%) 17 (16.0%) NS 
Number of males 81 (76.4%) 89 (84.0%) NS 
Smoker 54 (50.9%) 52 (49.1%) NS 
Non-smoker and ex-smoker 52 (49.1%) 54 (50.9%) NS 
Cigarette (per-day) 6.44 ± 0.79 6.71 ± 0.84 NS 
Employment duration (months) 65.39 ± 55.69 75.53 ± 73.63 NS 
NS: Not significant, p > 0.05. 
3.2. Respiratory Symptoms  
Respiratory symptoms among the workers and control group are presented in Table 2. 
Among the exposed workers 36.8% reported having phlegm. Other respiratory symptoms were 34% 
atopy, 27.4% wheezing, 25.5% cough and 14.2% dyspnea. These symptoms were not significantly 
different between the exposed workers and the control (unexposed) group. Comparison of exposed 
workers employment duration means by phlegm and atopy are presented in Table 3. 
Table 2. Respiratory symptoms among the exposed workers and the control (unexposed) group. 
 Exposed workers n (%) Control (unexposed) group n (%) p 
Cough 27 (25.5) 23 (21.7) NS 
Wheezing 29 (27.4) 28 (26.4) NS 
Dyspnea 15 (14.2) 16 (15.1) NS 
Phlegm 39 (36.8) 41 (38.7) NS 
Atopy 36 (34.0) 39 (36.8) NS 
NS: Not significant, p > 0.05. 
Table 3. Comparison of employment duration means by phlegm and atopy. 
Exposed workers 
Exposed workers Employment 
duration (month, Mean ± SD) 
p 
Phlegm (+) 76.28 ± 58.02 
p = 0.027 
Phlegm (−) 66.93 ± 69.36 
Atopy (+) 83.04 ± 73.71 
p = 0.019 
Atopy (−) 63.57 ± 59.41 
Cough (+) 65.78 ± 50.80 NS 
Cough (−) 65.26 ± 57.58 NS 
Wheezing (+) 71.24 ± 73.46 NS 
Wheezing (−) 63.19 ± 47.75 NS 
Dyspnea (+) 75.90 ± 67.88 NS 
Dyspnea (−) 63.66 ± 53.68 NS 
NS: Not significant, p > 0.05. 
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When the employment duration of the exposed workers with and without phlegm is compared, 
there was statistically significantly difference; the employment duration of the exposed workers with 
phlegm was longer than those without phlegm (p = 0.027). The duration of employment of those with 
atopy was found to be longer than those without (p = 0.019). Diagnosis of pulmonary diseases was put 
by only history taking in exposed workers and control group.  
Pulmonary diseases (tuberculosis, asthma, bronchitis) among the exposed workers and control 
group are presented in Table 4. 
Table 4. Tuberculosis, asthma, bronchitis among the exposed workers and control 
(unexposed) group. 
 Exposed workers (n = 10) Control (unexposed) group (n = 7) 
Tuberculosis 1 - 
Asthma 1 1 
Bronchitis 8 6 
PFTs were performed on 106 exposed workers and 106 (unexposed) controls. The results of PFTs 
of the exposed workers and the control (unexposed) group are presented in Table 5. 
Table 5. The descriptive statistics (including Mean ± SD) and the significance levels of 
PFTs of the exposed workers and the control (unexposed) group. 
PFT 
Exposed workers 
Actual value 
Control (unexposed) 
group Actual value 
p 
FEV1 (L/sc) 
3.68 ± 0.73 
(96.16 ± 11.75) * 
3.76 ± 0.55 
(98.43 ± 11.69) * 
NS 
FVC (L) 
4.31 ± 0.89 
(95.82 ± 12.61) * 
4.30 ± 0.64 
(96.28 ± 12.52) * 
NS 
FEV1/FVC (%) 
85.15 ± 5.94 
(104.13 ± 7.43) * 
85.84 ± 10.31 
(106.09 ± 8.02) * 
NS 
PEF (L/sc) 
7.29 ± 1.78 
(80.34 ± 13.97) * 
7.69 ± 1.60 
(84.52 ± 16.30) * 
NS 
FEF25–75 (L/sc) 
4.21 ± 1.13 
(88.99 ± 19.41) * 
4.46 ± 0.97 
(96.31 ± 21.16) * 
p = 0.01 
* Predict values %. NS: Not significant, p > 0.05. 
3.3. Pulmonary Function Test 
The mean % predicted of FEF25–75 of the exposed workers was found to be significantly lower than 
the control (unexposed) group (p = 0.01).  
4. Discussion 
In our study, symptoms were not significantly different between the exposed workers and the 
control (unexposed) group. Employment duration was higher in exposed workers with phlegm and 
atopy. The mean % predicted of FEF25–75 of the exposed workers was found to be significantly lower 
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than the control (unexposed) group. Exposure to dyes may be a potential health hazard. Reactive dyes 
are common causative agents for respiratory symptoms among dyehouse workers [4]. 
Workers employed in textile dyeing industries may have developed acute and chronic respiratory 
symptoms. In a study, prevalences of chronic respiratory symptoms in exposed workers were 
significantly higher than in control workers [15]. Park et al. reported that 25.2% of reactive-dye 
exposed workers had work-related lower respiratory symptoms [19]. In a survey which was conducted 
at 15 textile plants with dyehouses in western Sweden, 162 workers were exposed to reactive dyes and 
10 of these (6%) reported work-related respiratory symptoms [4]. In our study, there was no significant 
difference in respiratory symptoms (cough, wheezing, dyspnea) between the control and study group. 
Jiin et al. showed that cough is higher in workers when compared to unexposed workers (29% and 
14.8% respectively) [20]. According to Wang et al. symptom incidence at 3 months was 3.6%, for 
usual with phlegm, and 7% for usual dry cough [21]. High ECH exposure and low ECH exposure were 
significantly associated with cough plegm, chest tightness and dyspnea [20]. In our study, we also 
found cough symptoms in a similar ratio. Jiin et al. showed a linear relation between exposure and 
cough and sputum. In the study, the most common symptom was sputum and that symptom was seen 
more in the exposed workers [20].  
In our study, 36.8% of the exposed workers defined phlegm. Other respiratory symptoms were 34% 
atopy, 27.4% wheezing, 25.5% cough and 14.2% dyspnea. These symptoms were not significantly 
different between the exposed workers and the control (unexposed) group in our research. This might 
be due to the exposed workers and the control (unexposed) group had similar smoking habits, mean 
age and the employment durations of both two groups were similar and the “healthy workers effect”  
(a phenomenon observed initially in studies of occupational diseases, whereby workers usually exhibit 
lower overall death rates than the general population because severely ill and disabled people are 
typically excluded from employment).  
Raza et al. have suggested that morbidity among textile workers is due to smoking [22].  
Zuskin et al. found that the exposed nonsmoking workers had more complaints than the controls who 
were nonsmokers, and the respiratory symptoms were exacerbated by cigarette smoking [15]. 
However, Luo et al. showed that there was no significant relation between small airway abnormalities 
or obstructive lung abnormalities and smoking status [20]. In our study a significant correlation was 
detected between cigarette smoking and phlegm, wheezing and dyspnea. We could not analyse the 
effect of cigarette smoking by excluding other factors, as our study group was small and our study 
control group had a similar smoking history.  
After both short and long term exposures non smoking dyeing workers, primarly women, had 
significantly greater prevalence of dyspnea than controls [15]. Zuskin et al. reported that there were 
significantly higher prevalences of all chronic respiratory symptoms compared to the control workers 
among the male dyeing industry workers, and for the female dyeing workers, the differences were 
significant for dyspnea, rhinitis, sinusitis [15]. In another study, there were no significant differences in 
the prevalence of respiratory symptoms between men and women [23]. Females had significantly more 
complaints of chest tightness and dyspnea [20]. In our study gender results were similar for the study 
and control groups. 
A study by Zuskin et al. showed that in workers exposed for more than 10 years, there were 
significantly higher prevalences of chronic cough and chronic phlegm in smokers than in 
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nonsmokers [15]. Our finding was that employment duration was higher for exposed workers with 
phlegm and atopy. We didn’t discuss atopy, as we could not find that symptom in the literature.  
According to Pauluhn et al. the predominant dysfunction appeared to be consistent with obstructive 
rather than restrictive lung diseases [24]. Exposure and the onset of symptoms and objective evidence 
suggested that these symptoms were related to airflow limitation [2]. Workers demonstrated significant 
decreases in all ventilatory capacity tests in males and FEF50 and FEF25 for female workers [15]. 
Twenty-eight of 79 (35.4%) ECH exposed workers had obstructive or small airway lung lesions [20]. 
FEF25–75 may be used as a marker of initial bronchial damage [25]. In our study, the mean % predicted 
of FEF25–75 levels was significantly lower in the exposed workers. The Zuskin et al. Study 
environmental measurements were carried out at work place. Mesurements included fumes and gases, 
total and respirable dust samples [15,22].  
5. Conclusions 
To the best of our knowledge, this is the first study in our country (Turkey) which evaluates 
respiratory symptoms and PFTs of exposed workers who work in textile dyeing factories. Our study 
suggests that textile dyeing might cause some respiratory symptoms in exposed workers. It seems clear 
that exposure to reactive dyes should be considered a potential health hazard.  
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